Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FOSL1 |
| Upstream (Parents) |
|---|
| (<<) ATP13A2 → FOSL1 |
| (<<) GCNT3 → FOSL1 |
| (<<) PHLDA2 → FOSL1 |
| (<<) VPS37B → FOSL1 |
| (<<) EPHA2 → FOSL1 |
| (<<) ANXA2P2 → FOSL1 |
| (<<) CHAC1 → FOSL1 |
| (<<) S100A14 → FOSL1 |
| (<<) HN1 → FOSL1 |
| Downstream (Children) |
|---|
| FOSL1 → RHOF (>>) |
| FOSL1 → TCN1 (>>) |
| FOSL1 → GCNT3 (>>) |
| FOSL1 → DKK1 (>>) |
| FOSL1 → TRIM29 (>>) |
| FOSL1 → PRSS12 (>>) |
| FOSL1 → CDKN2A (>>) |
| FOSL1 → REEP1 (>>) |
| FOSL1 → GSTM1 (>>) |
| FOSL1 → ABCB9 (>>) |
| FOSL1 → HS3ST1 (>>) |
| FOSL1 → ZNF259P1 (>>) |
| FOSL1 → BARX2 (>>) |
| FOSL1 → IL18 (>>) |
| FOSL1 → ANP32E (>>) |
| FOSL1 → EPHA2 (>>) |
| FOSL1 → CHAC1 (>>) |
| FOSL1 → GSTM2 (>>) |
